These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 26799571)

  • 21. Management of Hepatitis C/HIV Coinfection in the Era of Highly Effective Hepatitis C Virus Direct-Acting Antiviral Therapy.
    Wyles DL; Sulkowski MS; Dieterich D
    Clin Infect Dis; 2016 Jul; 63 Suppl 1(Suppl 1):S3-S11. PubMed ID: 27363438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risks and benefits of antiretroviral therapy in HIV-HCV co-infected patients.
    Núñez M; Soriano V
    J Hepatol; 2005 Mar; 42(3):290-2. PubMed ID: 15710208
    [No Abstract]   [Full Text] [Related]  

  • 23. Update in HIV-hepatitis C virus coinfection in the direct acting antiviral era.
    Meissner EG
    Curr Opin Gastroenterol; 2017 May; 33(3):120-127. PubMed ID: 28234770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in the treatment of HIV/HCV coinfection in adults.
    Schlabe S; Rockstroh JK
    Expert Opin Pharmacother; 2018 Jan; 19(1):49-64. PubMed ID: 29252031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C and HIV Coinfection for Social Workers in Public Health, Medical and Substance Use Treatment Settings.
    Sims OT; Womack BG
    Soc Work Public Health; 2015; 30(4):325-35. PubMed ID: 25811121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Focus on drug interactions: the challenge of treating hepatitis C virus infection with direct-acting antiviral drugs in the HIV-positive patient.
    Rodríguez-Torres M
    Curr Opin Infect Dis; 2013 Feb; 26(1):50-7. PubMed ID: 23242341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug interactions in HIV-infected patients treated for hepatitis C.
    Soriano V; Labarga P; Fernandez-Montero JV; Mendoza C; Benítez-Gutiérrez L; Peña JM; Barreiro P
    Expert Opin Drug Metab Toxicol; 2017 Aug; 13(8):807-816. PubMed ID: 28689442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Guidelines for the management of HCV infection in HIV-infected patients. Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani].
    Antonucci G; Antinori A; Boumis E; De Longis P; Gentile M; Girardi E; Lauria FN; Narciso P; Noto P; Palmieri F; Oliva A; Petrosillo N; Rosati S; Urso R; Tocci G; Tozzi V; Visco Comandini U; Ippolito G
    Infez Med; 2004 Mar; 12(1):7-18. PubMed ID: 15329524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How will we manage acute HCV in men having sex with men in the era of all oral therapy?
    Boesecke C; Rockstroh JK
    J Viral Hepat; 2015 Jan; 22(1):2-7. PubMed ID: 25333810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV and HCV Therapies in 2016: Optimal Regimens.
    Sasadeusz J
    AIDS Rev; 2016; 18(4):212-221. PubMed ID: 27438581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Majority of HIV/HCV Patients Need to Switch Antiretroviral Therapy to Accommodate Direct Acting Antivirals.
    Cope R; Pickering A; Glowa T; Faulds S; Veldkamp P; Prasad R
    AIDS Patient Care STDS; 2015 Jul; 29(7):379-83. PubMed ID: 26066094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapeutic aspects of human immunodeficiency virus, hepatitis B and C coinfection].
    Bani-Sadr F
    Gastroenterol Clin Biol; 2003 May; 27(5):528-33. PubMed ID: 12843917
    [No Abstract]   [Full Text] [Related]  

  • 33. HCV-HIV co-infected patients: no longer a 'special' population?
    Sulkowski MS
    Liver Int; 2016 Jan; 36 Suppl 1():43-6. PubMed ID: 26725896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful sofosbuvir-based therapy in HIV/hepatitis C virus coinfected liver transplant recipients with recurrent hepatitis C virus infection.
    Grant JL; Hawkins C; Brooks H; Palella FJ; Koppe SW; Abecassis MM; Stosor V
    AIDS; 2016 Jan; 30(1):93-8. PubMed ID: 26731756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic Considerations in the Treatment of Hepatitis C Virus in Persons With HIV.
    MacBrayne CE; Kiser JJ
    Clin Infect Dis; 2016 Jul; 63 Suppl 1(Suppl 1):S12-23. PubMed ID: 27363437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid decline of anti-hepatitis C virus (HCV) antibodies following early treatment of incident HCV infections in HIV-infected men who have sex with men.
    Aebi-Popp K; Wandeler G; Salazar-Vizcaya L; Metzner K; Stöckle M; Cavassini M; Hoffmann M; Lüthi A; Suter F; Bernasconi E; Fehr J; Furrer H; Rauch A;
    HIV Med; 2018 Jul; 19(6):420-425. PubMed ID: 29573533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness and security of chronic hepatitis C treatment in coinfected patients in real-world.
    Uriarte-Pinto M; Navarro-Aznarez H; De La Llama-Celis N; Arazo-Garcés P; Martínez-Sapiña AM; Abad-Sazatornil MR
    Int J Clin Pharm; 2018 Jun; 40(3):608-616. PubMed ID: 29556931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treating HCV in HIV 2013: on the cusp of change.
    Martel-Laferrière V; Dieterich DT
    Liver Int; 2014 Feb; 34 Suppl 1():53-9. PubMed ID: 24373079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Coinfection with hepatitis C virus and HIV].
    Ruys TA; Reesink HW; Lange JM
    Ned Tijdschr Geneeskd; 2003 Oct; 147(42):2056-60. PubMed ID: 14606352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retrospective study of hepatitis C outcomes and treatment in HIV co-infected persons from the Australian HIV Observational Database.
    Puhr R; Wright ST; Hoy JF; Templeton DJ; Durier N; Matthews GV; Russell D; Law MG
    Sex Health; 2017 Aug; 14(4):345-354. PubMed ID: 28482168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.